← Back to guidelines
Allergy & Immunology371 papers

Viral gastroenteritis caused by Rotavirus

Last edited: 4/14/2026

Overview

Rotavirus gastroenteritis primarily affects infants and young children under five years old, causing significant morbidity and mortality, particularly in developing countries. Despite vaccination efforts, it remains a global health concern, leading to approximately 200,000 child deaths annually worldwide 1.

Diagnosis

  • Clinical presentation includes severe diarrhea, vomiting, fever, and dehydration 12.
  • Stool samples can confirm rotavirus infection through antigen detection or RT-PCR 1.
  • Laboratory tests may reveal electrolyte imbalances and signs of systemic infection 2.
  • Management

  • First-line treatment: Oral rehydration therapy (ORT) to prevent and treat dehydration 4.
  • Adjunctive treatments: Intravenous fluids for severe dehydration 2.
  • Monitoring: Close observation for complications such as disseminated intravascular coagulation (DIC) in severe cases 5.
  • Special Populations

  • Pediatrics: Primary target group; vaccination is highly recommended 13.
  • Adults: Rare but can present critically with multi-organ failure requiring intensive care management 2.
  • Comorbidities: No specific guidance provided; management focuses on supportive care and addressing complications 25.
  • Key Recommendations

  • Administer rotavirus vaccines (RotaTeq or Rotarix) according to the recommended schedule (2, 4, and 6 months for RV5; 2 and 4 months for RV1) to prevent severe gastroenteritis 3 (Evidence: Strong).
  • Prioritize oral rehydration therapy for treatment of dehydration in rotavirus gastroenteritis 4 (Evidence: Strong).
  • Vigilantly monitor and manage severe cases in adults and children for potential complications like DIC and multi-organ failure 25 (Evidence: Moderate).
  • References

    1 Sharma AD, Magdaleno JSL, Singh H, Orduz AFC, Cavallo L, Chawla M. Immunoinformatics-driven design of a multi-epitope vaccine targeting neonatal rotavirus with focus on outer capsid proteins VP4 and VP7 and non structural proteins NSP2 and NSP5. Scientific reports 2025. link 2 Edwards N, Abasszade JH, Nan K, Abrahams T, La PBD, Tinson AJ. Severe Adult Rotavirus Gastroenteritis: A Rare Case with Multi-Organ Failure and Critical Management. The American journal of case reports 2023. link 3 Hibbs BF, Miller ER, Shimabukuro T. Notes from the field: rotavirus vaccine administration errors--United States, 2006-2013. MMWR. Morbidity and mortality weekly report 2014. link 4 Madden V. An end to rotavirus misery. Nursing standard (Royal College of Nursing (Great Britain) : 1987) 2006. link 5 Limbos MA, Lieberman JM. Disseminated intravascular coagulation associated with rotavirus gastroenteritis: report of two cases. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996. link

    Original source

    1. [1]
    2. [2]
      Severe Adult Rotavirus Gastroenteritis: A Rare Case with Multi-Organ Failure and Critical Management.Edwards N, Abasszade JH, Nan K, Abrahams T, La PBD, Tinson AJ The American journal of case reports (2023)
    3. [3]
      Notes from the field: rotavirus vaccine administration errors--United States, 2006-2013.Hibbs BF, Miller ER, Shimabukuro T MMWR. Morbidity and mortality weekly report (2014)
    4. [4]
      An end to rotavirus misery.Madden V Nursing standard (Royal College of Nursing (Great Britain) : 1987) (2006)
    5. [5]
      Disseminated intravascular coagulation associated with rotavirus gastroenteritis: report of two cases.Limbos MA, Lieberman JM Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (1996)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG